Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2025-12-26 @ 2:55 AM
Study NCT ID:
NCT00711802
Status:
COMPLETED
Last Update Posted:
2018-09-05
First Post:
2008-07-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
Sponsor:
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2013-10-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-10-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-07
First Submit QC Date:
None
Study First Post Date:
2008-07-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-05-27
Results First Submit QC Date:
None
Results First Post Date:
2015-06-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-06
Last Update Post Date:
2018-09-05
Last Update Post Date Type:
ACTUAL